NM_007194.4:c.1102_1104delinsTAG
Variant summary
The NM_007194.4(CHEK2):c.1102_1104delinsTAG (p.Asp368Ter) variant causes a stop gained change. The variant is predicted to lead to nonsense-mediated mRNA decay (NMD). The gene CHEK2 is a tumor suppressor gene (CancerMine: 11 TSG, 7 oncogene, 5 driver citations). The gene CHEK2 is a known oncogene (CancerMine: 11 TSG, 7 oncogene, 5 driver citations). The gene CHEK2 is a cancer driver gene (CancerMine: 11 TSG, 7 oncogene, 5 driver citations). Note: allele frequency estimates from gnomAD may be inaccurate for this variant type (MNP or indel longer than 3 bp) due to technology limitations. The variant is absent from the gnomAD population database at sites with sufficient sequencing coverage. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_007194.4 stop_gained
Predictors
Clinical Significance
Conservation
Publications
- CHEK2-related cancer predispositionInheritance: AD Classification: DEFINITIVE Submitted by: Ambry Genetics, ClinGen
- Li-Fraumeni syndrome 2Inheritance: AD Classification: DEFINITIVE Submitted by: G2P
- hereditary breast carcinomaInheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- acute myeloid leukemiaInheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
- hereditary nonpolyposis colon cancerInheritance: Unknown Classification: LIMITED Submitted by: ClinGen
- familial ovarian cancerInheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
Genome browser will be placed here
Classification according to ACGS-UK Somatic Oncogenicity v2025
Our verdict: Pathogenic. The variant received 10 points.
| Apply | Criterion Code & Title / Strength | Rationale / Clinical Context | |
|---|---|---|---|
| O2Null variant in tumour suppressor gene | Frameshift/stop-gained, NMD predicted, LoF oncogenic mechanism — O2 very strong (+8); Use caution in the presence of multiple transcripts; Gene confirmed as TSG in CancerMine (TSG: 11 citations, oncogene: 7 citations, driver: 5 citations).; Frameshift/stop-gained. NMD predicted: true. LoF mechanism: true. Downstream pathogenic count: 0. | ||
| O3Absent or very rare in population | Absent or extremely rare in gnomAD (AC ≤ 2) — O3 moderate; GnomAD: AF = absent, AC = 0 — absent/extremely rare (O3 moderate [+2]) |
Variant Effect in Transcripts
Automated classification analysis was done for transcript: NM_007194.4. You can select a different transcript below to see updated classification assignments.
RefSeq Transcripts
| Sel. | Gene / Transcript | Tags | HGVSc / HGVSp | Effect | Exon rank | Protein / UniProt |
|---|---|---|---|---|---|---|
CHEK2 | MANE Select | c.1102_1104delinsTAG p.Asp368Ter | stop_gained | Exon 11 of 15 | Prot: NP_009125.1 | |
CHEK2 | c.1231_1233delinsTAG p.Asp411Ter | stop_gained | Exon 12 of 16 | Prot: NP_001005735.1 | ||
CHEK2 | c.1195_1197delinsTAG p.Asp399Ter | stop_gained | Exon 12 of 16 | Prot: NP_001425222.1 |
Ensembl Transcripts
| Sel. | Gene / Transcript | Tags | HGVSc / HGVSp | Effect | Exon rank | Protein / UniProt |
|---|---|---|---|---|---|---|
CHEK2 | MANE Select | c.1102_1104delinsTAG p.Asp368Ter | stop_gained | Exon 11 of 15 | Prot: ENSP00000385747 | |
CHEK2 | TSL:1 | c.1231_1233delinsTAG p.Asp411Ter | stop_gained | Exon 12 of 16 | Prot: ENSP00000372023 | |
CHEK2 | TSL:1 | c.829_831delinsTAG p.Asp277Ter | stop_gained | Exon 8 of 12 | Prot: ENSP00000384919 |
Frequencies
Allele frequencies (AF), counts (AC/AN), homozygotes and coverage
| Source / population | AF | AC | Hom | AN | Coverage |
|---|---|---|---|---|---|
Global population databases 2 sources | |||||
GnomAD3 genomes | Cov:32 | ||||
GnomAD4 genome | Cov:32 | ||||
ClinVar
Not reported inComputational Scores
| Algorithm | Calibrated pred. | Score | Prediction |
|---|---|---|---|
PhyloP100 | Uncertain | 6.9 |
Splicing Scores
No splicing scores have been computed for this variant.
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.
MaveDB functional evidence
- Gene
- CHEK2
- Assay type
- Cell fitness
- Mechanism
- DNA damage checkpoint signaling
- Model system
- Yeast (Saccharomyces cerevisiae)
- Score
- -2.06 · p.Asp368Ter (assay numbering)